Literature DB >> 33692964

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Jiachen Liu1, Yantao Xu1, Bimei Jiang2.   

Abstract

Since the 1950s, gradual changes in the gut microbiota of patients with hepatic encephalopathy have been observed. Previous research has indicated potential associations between the gut and brain, and the gut microbiota is becoming a hot topic in research on diseases of the nervous system. However, for the past few decades, studies of hepatic encephalopathy have been restricted to controlling the gut microbiota during macroscopic manipulation, such as probiotic intervention, while its clinical use remains controversial, and the cellular mechanisms underlying this condition are still poorly understood. This thesis seeks to comprehensively understand and explain the role of gut microbiota in hepatic encephalopathy as well as analyze the effects of intervention by regulating the gut microbiota. Evidence is presented that shows that dysbiosis of the gut microbiota is the primary pathological driver of hepatic encephalopathy and impacts pathologic progression via complex regulatory networks. As a result, suggestions were identified for future mechanistic research and improvements in therapeutic strategies for hepatic encephalopathy.
Copyright © 2021 Liu, Xu and Jiang.

Entities:  

Keywords:  antibiotics; fecal microbiota transplantation; gut microbiota; gut–liver–brain axis; hepatic encephalopathy; probiotic

Mesh:

Year:  2021        PMID: 33692964      PMCID: PMC7937792          DOI: 10.3389/fcimb.2021.586427

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  93 in total

1.  Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF).

Authors:  Sara Montagnese; Francesco Paolo Russo; Piero Amodio; Patrizia Burra; Antonio Gasbarrini; Carmela Loguercio; Giulio Marchesini; Manuela Merli; Francesca Romana Ponziani; Oliviero Riggio; Carmelo Scarpignato
Journal:  Dig Liver Dis       Date:  2018-12-12       Impact factor: 4.088

Review 2.  Gut microbiome and liver disease.

Authors:  Naga S Betrapally; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

3.  Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy.

Authors:  Christian Schulz; Kerstin Schütte; Ramiro Vilchez-Vargas; Riccardo Vasapolli; Peter Malfertheiner
Journal:  Dig Dis       Date:  2018-11-14       Impact factor: 2.404

4.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Authors:  Jasmohan S Bajaj; Phillip B Hylemon; Jason M Ridlon; Douglas M Heuman; Kalyani Daita; Melanie B White; Pamela Monteith; Nicole A Noble; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-19       Impact factor: 4.052

Review 5.  Pharmacologic Management of Hepatic Encephalopathy.

Authors:  Noah Y Mahpour; Lauren Pioppo-Phelan; Mishal Reja; Augustine Tawadros; Vinod K Rustgi
Journal:  Clin Liver Dis       Date:  2020-03-02       Impact factor: 6.126

Review 6.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 7.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

8.  Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.

Authors:  Runping Liu; Jason D Kang; R Balfour Sartor; Masoumeh Sikaroodi; Andrew Fagan; Edith A Gavis; Huiping Zhou; Phillip B Hylemon; Jeremy W Herzog; Xiaojiaoyang Li; Robert H Lippman; Javier Gonzalez-Maeso; James B Wade; Siddhartha Ghosh; Emily Gurley; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.298

9.  Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction.

Authors:  Wei-Wei Wang; Yu Zhang; Xiao-Bing Huang; Nan You; Lu Zheng; Jing Li
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

10.  Bacteriophages as potential new mammalian pathogens.

Authors:  George V Tetz; Kelly V Ruggles; Hua Zhou; Adriana Heguy; Aristotelis Tsirigos; Victor Tetz
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.